Abou-Alfa, G K <br/><br/>
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  06 2018 
 - 1402-1408 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdy101  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Hepatocellular--pathology<br/>Combined Modality Therapy<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Hydrolases--therapeutic use<br/>Liver Neoplasms--pathology<br/>Male<br/>Middle Aged<br/>Palliative Care<br/>Polyethylene Glycols--therapeutic use<br/>Prognosis<br/>Survival Rate